Next-Generation Antibody-Drug Conjugates Demonstrate Remarkable Potential in Early-Stage Disease
In a groundbreaking development presented at the ESMO Congress 2025, the oncology field witnesses a transformative leap forward with the ...
In a groundbreaking development presented at the ESMO Congress 2025, the oncology field witnesses a transformative leap forward with the ...
In a groundbreaking advancement that could revolutionize cancer therapy, researchers have unveiled a novel approach employing gold nanoparticles for targeted ...
In a groundbreaking advancement in cancer immunotherapy, scientists at University College London (UCL) have successfully engineered a rare subset of ...
In the ongoing battle against cancer, where traditional drug development faces steep challenges such as prolonged timelines and exorbitant costs, ...
For decades, the intricate relationship between psychological stress and cancer progression has been acknowledged within clinical settings, yet the precise ...
In a breakthrough that could redefine the landscape of cancer therapeutics, researchers at the Center for Research in Biological Chemistry ...
A recent breakthrough in the treatment of HER2-positive alpha-fetoprotein-producing gastric cancer (AFPGC) offers a new beacon of hope for patients ...
Triple-negative breast cancer (TNBC) is notorious for its aggressive nature and resistance to conventional therapies, creating an urgent need for ...
In a groundbreaking development that has captured the attention of the oncology community, recent findings from the NRG-BN001 trial’s proton ...
In the relentless quest to combat acute myeloid leukemia (AML), a devastating blood cancer affecting roughly 20,000 Americans annually, researchers ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine